Case Report
Published on 22 Oct 2020
Hematological Toxicity During Concomitant Treatment With Ruxolitinib and Avelumab for Merkel Cell Carcinoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2020.579914
- 5,821 views
- 5 citations




